Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
CStone sells to Servier its exclusive rights to TIBSOVO® in Greater China and Singapore 2023-12-21 17:10
BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with IMFINZI for the Treatment of Advanced Hepatocellular Carcinoma in a Phase Ib/II Trial 2023-12-21 08:26
YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting 2023-12-21 05:30
/DISREGARD RELEASE: YS Biopharma/ 2023-12-21 05:15
Genevoyager Unveils Gene Therapy CDMO Facility in Milestone Move 2023-12-20 23:10
Dx&Vx co-develops a bio-healthcare big data platform with LG CNS 2023-12-20 22:00
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals to Showcase Ongoing Parkinson's Disease Program at the 7th Annual Sachs Associates Neuroscience Innovation Forum 2023-12-20 20:00
Fapon Shines at JITMM 2023 2023-12-20 17:39
InxMed Enters License Agreement with Escugen to Develop Next-Generation ADCs 2023-12-20 09:00
Standigm named as a Tech Innovator in Generative AI in Drug Discovery use case 2023-12-19 22:00
New Drug Application of Mabwell's 8MW0511 for Injection Accepted by NMPA 2023-12-19 20:00
Roche navify digital solutions get excellent ratings from healthcare professionals in KLAS Research reports 2023-12-19 14:00
Innovent and AnHeart Therapeutics Announce the National Medical Products Administration of China Has Granted Taletrectinib (ROS1 Inhibitor) Priority Review Designation 2023-12-19 08:00
Tsingke Congratulates iGEM 2023 SYSU-Software on Winning GOLD MEDAL for BioRocket Project 2023-12-18 22:13
RNAimmune Receives Investigational New Drug Application Clearance from U.S. FDA for mRNA-Based Respiratory Syncytial Virus Vaccine RV-1770 2023-12-18 22:04
RemeGen Announces Continued Inclusion of Telitacicept and Disitamab Vedotin in China National Reimbursement Drug List, Ensuring Continuous Accessibility of Innovative Drugs for More Patients 2023-12-18 20:56
Biocon Biologics Concludes Integration of Acquired Biosimilars Business in ~120 countries 2023-12-18 20:44
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI) 2023-12-18 09:49
Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications 2023-12-18 08:00
First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM 2023-12-17 23:15
1 61 62 63 64 65 451